Braidwell »

Billiontoone Inc Cl A shares owned by Braidwell

Quarter-by-quarter ownership of Billiontoone Inc Cl A (BLLN) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Billiontoone Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including Billiontoone Inc Cl A held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Billiontoone Inc Cl A by Braidwell

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.1M 50k 81.84

More positions owned by Braidwell

Caris Life Sciences (CAI)
Guardant Health Debt 1.250% 2/1 (Principal)
Edgewise Therapeutics (EWTX)
Repligen Corp Note 1.000%12/1 (Principal)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Neogenomics Note 0.250% 1/1 (Principal)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Hinge Health Cl A (HNGE)
Align Technology (ALGN)
Kodiak Sciences (KOD)
Soleno Therapeutics (SLNO)

View all positions for Braidwell

Top funds holding Billiontoone Inc Cl A

Adams Street Partners
Baillie Gifford & Co
Neuberger Berman Group
Vanguard Group
Ubs Global Asset Management Americas
Invesco
Emerald Advisers
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Emerald Mutual Fund Advisers, Trust
T. Rowe Price Investment Management
Geode Capital Management
Braidwell
Lord, Abbett & Co
MYDA Advisors

View all funds holding Billiontoone Inc Cl A